Analyst Ratings for Cardiff Oncology (CRDF) [Buys]
CRDF Rating Summary
CRDF Price Target Summary
- Highest: $14.00 (H.C. Wainwright)
- Lowest: $7.00 (Piper Sandler)
- Average: $10.50
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$10.50 (+151.2%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
Rating Score: 10 / 10
Percentile Rank: 95%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 1/5/2022 | William Blair | Andy T. Hsieh | New Coverage | Outperform (N/A) |
N/A (N/A) |
6.29 (4.18) |
-33.55% | Details |
| 12/8/2021 | Baird » Updated 8/29/2022 |
Joel L. Beatty | New Coverage | Outperform (N/A) |
6.00 (9.00) |
5.28 (4.18) |
-20.83% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
